Frederick Edwards to senior VP-marketing, succeeding David Eisenberg who was recently named exec VP and chief operating officer; William Eagleson to senior VP-distribution & merchandise control; Leonard DeMino to corporate VP-pharmacy; and Joseph Pollard to senior VP-corporate relations & advertising.
You may also be interested in...
Early results from its novel antiviral are encouraging, but demonstrating life-saving qualities in a short window of time will be tricky.
After federal agencies invested almost $5600m to ensure Cue Health could scale up production, FDA announces the self-administered test will be available OTC. it's the agency's first emergency use authorization for an at-home molecular diagnostic test available nonprescription.
Tezepelumab was among four products that the European Medicines Agency most recently considered for review under its accelerated assessment mechanism.